Migdal Insurance & Financial Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Buy |
+59
| New | +$31K | ﹤0.01% | 294 |
|
|
2021
Q2 | – | Sell |
-1,376
| Closed | -$651K | – | 659 |
|
|
2021
Q1 | $651K | Buy |
1,376
+860
| +167% | +$407K | 0.01% | 293 |
|
|
2020
Q4 | $249K | Buy |
+516
| New | +$249K | ﹤0.01% | 292 |
|
|
2018
Q4 | – | Sell |
-553
| Closed | -$223K | – | 794 |
|
|
2018
Q3 | $223K | Buy |
553
+328
| +146% | +$132K | ﹤0.01% | 505 |
|
|
2018
Q2 | $78K | Buy |
225
+218
| +3,114% | +$75.6K | ﹤0.01% | 546 |
|
|
2018
Q1 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 618 |
|
|
2017
Q1 | – | Sell |
-36
| Closed | -$13K | – | 490 |
|
|
2016
Q4 | $13K | Buy |
+36
| New | +$13K | ﹤0.01% | 386 |
|